Pharmaceutical CDMO Invests $43M in Lyophilization Capacity


Oct 14, 2013

Construction of new German production building with large scale freeze drying capability will increase the company’s lyophilization capacity.

Recipharm, a contract development and manufacturing organization supplying the global pharmaceuticals market, will invest $43 million in its Wasserburg site located near Munich. The capital will be used to create a new building that will house a fourth production area adding to the three already in operation. This development will significantly increase the company’s lyophilization capacity and will result in a brand new state of the art facility equipped with the latest automatic loading and unloading technology.

Read the press release here

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments